Deuterium Capital Management LLC Has $2.72 Million Stake in Core Scientific, Inc. (NASDAQ:CORZ)

Deuterium Capital Management LLC increased its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 58.9% during the 4th quarter, Holdings Channel reports. The firm owned 190,723 shares of the company’s stock after purchasing an additional 70,723 shares during the quarter. Core Scientific comprises approximately 7.1% of Deuterium Capital Management LLC’s portfolio, making the stock its 5th biggest holding. Deuterium Capital Management LLC’s holdings in Core Scientific were worth $2,717,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Rush Island Management LP purchased a new stake in Core Scientific during the third quarter valued at about $32,221,000. Taconic Capital Advisors LP lifted its position in Core Scientific by 178.7% in the 3rd quarter. Taconic Capital Advisors LP now owns 2,717,462 shares of the company’s stock worth $32,229,000 after buying an additional 1,742,462 shares during the last quarter. Mirabella Financial Services LLP purchased a new stake in Core Scientific in the third quarter worth approximately $18,383,000. Geode Capital Management LLC boosted its stake in Core Scientific by 26.7% in the third quarter. Geode Capital Management LLC now owns 5,276,573 shares of the company’s stock worth $62,594,000 after buying an additional 1,113,285 shares in the last quarter. Finally, Whitefort Capital Management LP grew its position in Core Scientific by 337.1% during the third quarter. Whitefort Capital Management LP now owns 1,147,500 shares of the company’s stock valued at $13,609,000 after acquiring an additional 885,000 shares during the last quarter.

Insider Buying and Selling at Core Scientific

In related news, insider Todd M. Duchene sold 25,277 shares of the stock in a transaction dated Friday, January 24th. The shares were sold at an average price of $16.24, for a total value of $410,498.48. Following the completion of the transaction, the insider now directly owns 2,023,423 shares in the company, valued at $32,860,389.52. This trade represents a 1.23 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Adam Taylor Sullivan sold 369,712 shares of the business’s stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $16.24, for a total transaction of $6,004,122.88. Following the sale, the chief executive officer now directly owns 3,758,793 shares in the company, valued at $61,042,798.32. The trade was a 8.96 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 614,032 shares of company stock valued at $9,534,916. 32.00% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on CORZ shares. Compass Point cut their price objective on shares of Core Scientific from $26.00 to $20.00 and set a “buy” rating for the company in a research note on Tuesday, February 25th. B. Riley upped their price target on shares of Core Scientific from $16.00 to $17.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Keefe, Bruyette & Woods started coverage on Core Scientific in a report on Monday, January 27th. They issued an “outperform” rating and a $22.00 price objective on the stock. BTIG Research increased their target price on Core Scientific from $19.00 to $20.00 and gave the company a “buy” rating in a report on Monday, December 16th. Finally, Cantor Fitzgerald reduced their price target on Core Scientific from $24.00 to $21.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $19.07.

Core Scientific Stock Down 5.4 %

Shares of CORZ stock opened at $9.59 on Wednesday. The firm has a market capitalization of $2.68 billion and a price-to-earnings ratio of -1.77. The stock has a fifty day moving average of $13.02 and a 200 day moving average of $13.34. Core Scientific, Inc. has a 52 week low of $2.61 and a 52 week high of $18.63.

Core Scientific (NASDAQ:CORZ) last posted its earnings results on Wednesday, February 26th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.09. The company had revenue of $94.93 million during the quarter, compared to analysts’ expectations of $97.07 million. Equities research analysts anticipate that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.